Dr. Reddy's Laboratories Ltd. reported fourth-quarter stand-alone net profit of Rs.378.15 crore, up from Rs.211.79 crore for the quarter ended March 31, 2012. Total income grew to Rs.2,451.27 crore from the Rs.2,051.18 crore in the corresponding quarter of the preceding year.
On a consolidated basis, the company's fourth-quarter consolidated net profit attributable to equity holders rose to Rs.571.01 crore from the Rs.342.70 crore in Q4FY12. Total income increased to Rs.3,503.04 crore from the Rs.2,678.25 crore last year.
The company's Board has recommended a final dividend of 300 percent or Rs.15.00 per equity share of Rs.5 each for the fiscal year 2013 to be paid on or after August 07.
At the BSE, Dr. Reddy's Laboratories shares are currently trading at Rs.2,040.15, down 1.96 percent from the previous close.
For comments and feedback: editorial@rttnews.com